To further determine whether the activation of Wnt/β-catenin in breast cancer cells is eIF4E-dependent, we depleted eIF4E using two independent siRNAs in breast cancer cells (Supplementary Figure S1) and examined β-catenin activities in these cells exposed to chemotherapeutic drugs. The gene discussed is EIF4E; the disease is breast cancer.